The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer

被引:256
作者
Akamatsu, Shusuke [1 ,2 ]
Wyatt, Alexander W. [1 ,2 ]
Lin, Dong [1 ,2 ,3 ]
Lysakowski, Summer [1 ,2 ]
Zhang, Fan [1 ,2 ]
Kim, Soojin [1 ,2 ]
Tse, Charan [1 ,2 ]
Wang, Kendric [1 ,2 ]
Mo, Fan [1 ,2 ]
Haegert, Anne [1 ,2 ]
Brahmbhatt, Sonal [1 ,2 ]
Bell, Robert [1 ,2 ]
Adomat, Hans [1 ,2 ]
Kawai, Yoshihisa [1 ,2 ]
Xue, Hui [3 ]
Dong, Xin [3 ]
Fazli, Ladan [1 ,2 ]
Tsai, Harrison [4 ]
Lotan, Tamara L. [4 ]
Kossai, Myriam [5 ,6 ]
Mosquera, Juan Miguel [5 ,6 ]
Rubin, Mark A. [5 ,6 ]
Beltran, Himisha [6 ,7 ]
Zoubeidi, Amina [1 ,2 ]
Wang, Yuzhuo [1 ,2 ,3 ]
Gleave, Martin E. [1 ,2 ]
Collins, Colin C. [1 ,2 ]
机构
[1] Univ British Columbia, Vancouver Prostate Ctr, Vancouver, BC V6H 3Z6, Canada
[2] Univ British Columbia, Dept Urol Sci, Vancouver, BC V6H 3Z6, Canada
[3] BC Canc Agcy, Dept Expt Therapeut, Vancouver, BC V5Z 1L3, Canada
[4] Johns Hopkins Sch Med, Dept Pathol, Baltimore, MD 21287 USA
[5] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10065 USA
[6] Weill Cornell Med Coll, New York Presbyterian Hosp, Inst Precis Med, New York, NY 10065 USA
[7] Weill Cornell Med Coll, Dept Med, Div Hematol & Med Oncol, New York, NY 10065 USA
基金
加拿大健康研究院;
关键词
EPITHELIAL-MESENCHYMAL TRANSITION; SMALL-CELL CARCINOMA; TGF-BETA; EXPRESSION PROFILE; INCREASED SURVIVAL; TUMOR PROGRESSION; PATHWAY; DISEASE; TARGETS; SNAIL;
D O I
10.1016/j.celrep.2015.07.012
中图分类号
Q2 [细胞生物学];
学科分类号
071013 [干细胞生物学];
摘要
More potent targeting of the androgen receptor (AR) in advanced prostate cancer is driving an increased incidence of neuroendocrine prostate cancer (NEPC), an aggressive and treatment-resistant AR-negative variant. Its molecular pathogenesis remains poorly understood but appears to require TP53 and RB1 aberration. We modeled the development of NEPC from conventional prostatic adenocarcinoma using a patient-derived xenograft and found that the placental gene PEG10 is de-repressed during the adaptive response to AR interference and subsequently highly upregulated in clinical NEPC. We found that the AR and the E2F/RB pathway dynamically regulate distinct post-transcriptional and post-translational isoforms of PEG10 at distinct stages of NEPC development. In vitro, PEG10 promoted cell-cycle progression from G0/G1 in the context of TP53 loss and regulated Snail expression via TGF-beta signaling to promote invasion. Taken together, these findings show the mechanistic relevance of RB1 and TP53 loss in NEPC and suggest PEG10 as a NEPC-specific target.
引用
收藏
页码:922 / 936
页数:15
相关论文
共 48 条
[1]
Targeting the TGFβ signalling pathway in disease [J].
Akhurst, Rosemary J. ;
Hata, Akiko .
NATURE REVIEWS DRUG DISCOVERY, 2012, 11 (10) :790-811
[2]
Platinum-Based Chemotherapy for Variant Castrate-Resistant Prostate Cancer [J].
Aparicio, Ana M. ;
Harzstark, Andrea L. ;
Corn, Paul G. ;
Wen, Sijin ;
Araujo, John C. ;
Tu, Shi-Ming ;
Pagliaro, Lance C. ;
Kim, Jeri ;
Millikan, Randall E. ;
Ryan, Charles ;
Tannir, Nizar M. ;
Zurita, Amado J. ;
Mathew, Paul ;
Arap, Wadih ;
Troncoso, Patricia ;
Thall, Peter F. ;
Logothetis, Christopher J. .
CLINICAL CANCER RESEARCH, 2013, 19 (13) :3621-3630
[3]
Steroid Hormone Receptors in Prostate Cancer: A Hard Habit to Break? [J].
Attard, Gerhardt ;
Cooper, Colin S. ;
de Bono, Johann S. .
CANCER CELL, 2009, 16 (06) :458-462
[4]
Challenges in Recognizing Treatment-Related Neuroendocrine Prostate Cancer [J].
Beltran, Himisha ;
Tagawa, Scott T. ;
Park, Kyung ;
MacDonald, Theresa ;
Milowsky, Matthew I. ;
Mosquera, Juan Miguel ;
Rubin, Mark A. ;
Nanus, David M. .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (36) :E386-E389
[5]
Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets [J].
Beltran, Himisha ;
Rickman, David S. ;
Park, Kyung ;
Chae, Sung Suk ;
Sboner, Andrea ;
MacDonald, Theresa Y. ;
Wang, Yuwei ;
Sheikh, Karen L. ;
Terry, Stephane ;
Tagawa, Scott T. ;
Dhir, Rajiv ;
Nelson, Joel B. ;
de la Taille, Alexandre ;
Allory, Yves ;
Gerstein, Mark B. ;
Perner, Sven ;
Pienta, Kenneth J. ;
Chinnaiyan, Arul M. ;
Wang, Yuzhuo ;
Collins, Colin C. ;
Gleave, Martin E. ;
Demichelis, Francesca ;
Nanus, David M. ;
Rubin, Mark A. .
CANCER DISCOVERY, 2011, 1 (06) :487-495
[6]
IKKα controls canonical TGFβ-SMAD signaling to regulate genes expressing SNAIL and SLUG during EMT in Panc1 cells [J].
Brandl, Martina ;
Seidler, Barbara ;
Haller, Ferdinand ;
Adamski, Jerzy ;
Schmid, Roland M. ;
Saur, Dieter ;
Schneider, Guenter .
JOURNAL OF CELL SCIENCE, 2010, 123 (24) :4231-4239
[7]
Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process [J].
Chandran, Uma R. ;
Ma, Changqing ;
Dhir, Rajiv ;
Bisceglia, Michelle ;
Lyons-Weiler, Maureen ;
Liang, Wenjing ;
Michalopoulos, George ;
Becich, Michael ;
Monzon, Federico A. .
BMC CANCER, 2007, 7 (1)
[8]
Pathogenesis of prostatic small cell carcinoma involves the inactivation of the P53 pathway [J].
Chen, Hongbing ;
Sun, Yin ;
Wu, Chengyu ;
Magyar, Clara E. ;
Li, Xinmin ;
Cheng, Liang ;
Yao, Jorge L. ;
Shen, Steven ;
Osunkoya, Adeboye O. ;
Liang, Chaozhao ;
Huang, Jiaoti .
ENDOCRINE-RELATED CANCER, 2012, 19 (03) :321-331
[9]
Neuroendocrine differentiation prostate cancer: From lab to bedside [J].
Cindolo, Luca ;
Cantile, Monica ;
Vacherot, Francis ;
Terry, Stephane ;
de la Taille, Alexandre .
UROLOGIA INTERNATIONALIS, 2007, 79 (04) :287-296
[10]
Mammalian gene PEG10 expresses two reading frames by high efficiency-1 frameshifting in embryonic-associated tissues [J].
Clark, Michael B. ;
Jaenicke, Martina ;
Gottesbuehren, Undine ;
Kleffmann, Torsten ;
Legge, Michael ;
Poole, Elizabeth S. ;
Tate, Warren P. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (52) :37359-37369